Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
01/2002
01/31/2002CA2412626A1 Il-17 molecules and uses thereof
01/31/2002CA2412544A1 Polypeptide delivery ii-2
01/30/2002EP1176189A1 Stem cell-like cells
01/30/2002EP1175513A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA
01/30/2002EP1175506A2 Compound screening method
01/30/2002EP0956009B1 Treatment of neurodegenerative conditions with nimesulide
01/30/2002EP0888373A4 Smooth muscle cell lim protein
01/30/2002CN1333828A Compositions and methods for increasing bone mineralization
01/30/2002CN1333339A Polytype gene of MXA protein and application thereof
01/24/2002WO2002006535A2 Method for breeding disease resistant domesticated fowl
01/24/2002WO2002006492A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction
01/24/2002WO2002005842A2 Preventing airway mucus production by administration of egf-r antagonists
01/24/2002WO2002005634A2 Transgenic animal and methods
01/24/2002WO2002005633A1 P300 transgenic animal
01/24/2002WO2001060794A3 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease
01/24/2002WO2001046258A3 Transporters and ion channels
01/24/2002WO2001042465A3 Chordin-like molecules and uses thereof
01/24/2002WO2000073453A9 T-bet compositions and methods of use thereof
01/24/2002US20020010949 Cloning using donor nuclei from differentiated fetal and adult cells
01/24/2002US20020010948 Swine defective for transmission of porcine endogenous retrovirus and uses thereof
01/24/2002US20020010947 Transgenic mouse model of human neurodegenerative disease
01/24/2002US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof
01/24/2002US20020009704 Preparing oocyte for cryogenic suspension; suspend sample in freeze resistant nutrient, rinse, drop onto solid solid surface with good heat conductivity
01/24/2002US20020009452 Method for altering undesirable immune responses to polypeptides
01/24/2002US20020008105 Container for delivery of useful organisms
01/24/2002CA2415557A1 Compounds for the treatment of sexual dysfunction
01/24/2002CA2415325A1 Preventing airway mucus production by administration of egf-r antagonists
01/23/2002EP1173571A2 Human ion channel proteins
01/23/2002EP1173485A1 Human antibodies to staphylococcus aureus
01/23/2002EP1173189A1 Asialocytokines and treatment of liver disease
01/17/2002WO2002004621A2 Methods of creating constructs useful for introducing sequences into embryonic stem cells
01/17/2002WO2002004611A2 Aminoacyl trna synthetases
01/17/2002WO2002004609A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility
01/17/2002WO2002004513A2 Down syndrome critical region 1-like 1 proteins
01/17/2002WO2002004511A2 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
01/17/2002WO2002004509A2 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells
01/17/2002WO2002004489A2 Polymorphic kinase anchor proteins and nucleic acids encoding the same
01/17/2002WO2002004020A2 Pathogen resistance in organisms
01/17/2002WO2002003911A2 Prevention and treatment of alzheimer's disease
01/17/2002WO2002003786A1 Method of culturing zooplankton, apparatus for culturing by the same, and culture obtained by the same
01/17/2002WO2001072962A3 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
01/17/2002WO2001049106A3 Method for cloning animals with targetted genetic alterations
01/17/2002WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof
01/17/2002WO2001044448A3 Human oxidoreductase proteins
01/17/2002WO2001023541A3 Compositions and methods for altering gene expression
01/17/2002US20020007197 Method for testing a technique intended to predict onset of heart arrhythmia using an animal test subject
01/17/2002US20020005076 System and method of flow cytometry and sample handling
01/17/2002CA2415422A1 Chromosome 3p21.3 genes are tumor suppressors
01/17/2002CA2415350A1 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility
01/17/2002CA2415127A1 Down syndrome critical region 1-like 1 proteins
01/17/2002CA2414495A1 Polymorphic kinase anchor proteins and nucleic acids encoding the same
01/17/2002CA2413810A1 Aminoacyl trna synthetases
01/16/2002EP1172375A1 Gene expression, genome alteration and reporter gene expression in myofibroblasts and myofibroblasts-like cells by using the regulatory regions within the alpha smooth muscle alpha-actin gene
01/16/2002EP1171628A2 Compound screening methods
01/16/2002EP1171609A2 Lipoxygenase proteins and polynucleotides encoding the same
01/16/2002EP1171595A1 13 transmembrane protein expressed in prostate cancer
01/16/2002EP1171157A2 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
01/16/2002EP1170994A1 Transgenic animals expressing salivary proteins
01/16/2002EP1170993A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1
01/15/2002US6339183 A vector containing a promoter linked to a heterologous gene that directs expression into the urogenital epithelium of transgenic animals, turning the bladder into a bioreactor; for recovering biologically active molecules from urine
01/15/2002US6338220 Eradication of mosquitoes
01/10/2002WO2002003069A1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME
01/10/2002WO2002002769A1 A novel app mutation associated with an unusual alzheimer's disease pathology
01/10/2002WO2002002765A2 Chimeric promoters for controlling expression in smooth muscle cells
01/10/2002WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
01/10/2002WO2002002624A2 B7-like molecules and uses thereof
01/10/2002WO2002001950A2 Transgenic mice containing targeted gene disruptions
01/10/2002WO2002001949A2 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on the oestrogen receptor and its intracellular receptors, and method for the preparation thereof
01/10/2002WO2001085973A9 Antisense type gene trap vector
01/10/2002WO2001070775A3 Wnt-1 related polypeptides, and nucleic acids encoding the same
01/10/2002WO2001050883A3 Rearing of aquatic species with dha-rich prey organisms
01/10/2002WO2001048483A3 Method for screening of appetite control agents
01/10/2002WO2001042444A3 Methods for expression of genes in primates
01/10/2002WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
01/10/2002WO2001017344A3 A method of transgenic fowl construction
01/10/2002WO2000075347A3 Tet repressor-based transcriptional regulatory proteins
01/10/2002WO2000075300A3 Methods for manipulating the avian genome
01/10/2002US20020004938 Models of prion disease
01/10/2002US20020004937 Method for detecting an aberrant animal-derived prion gene and a prion gene modified mouse which exhibits heart anomalies
01/10/2002US20020004586 Prion-binding activity in serum and proteins
01/10/2002US20020004240 Method and system for introducing a gene into a human stem cell
01/10/2002US20020004043 Cellular and animal models for diseases associated with altered mitochondrial function
01/10/2002CA2416292A1 Transgenic mice containing targeted gene disruptions
01/10/2002CA2414328A1 Chimeric promoters for controlling expression in smooth muscle cells
01/10/2002CA2413262A1 B7-like molecules and uses thereof
01/10/2002CA2412925A1 A novel app mutation associated with an unusual alzheimer's disease pathology
01/09/2002EP1170364A1 Mutations of cryptic splice sites in Cre and Cre-fusion proteins to improve the expression in inducibility
01/09/2002EP1169475A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy
01/09/2002EP1169472A2 Compound assay using nematodes
01/09/2002EP1169471A2 Method for screening compounds using nematode worms
01/09/2002EP0959907A4 The butyrophilin gene promoter and uses thereof
01/09/2002CN1329822A Electrostatic method and equipment for processing silk moth eggs
01/08/2002US6337391 Polycation-sensing receptor in aquatic species and methods of use
01/03/2002WO2002000710A2 B7-like molecules and uses thereof
01/03/2002WO2002000262A2 Modulation of chromosome function by chromatin remodeling agents
01/03/2002WO2002000017A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5
01/03/2002WO2002000016A1 Altered wool and hair fibres
01/03/2002WO2001053344A3 Chondromodulin-i related peptide
01/03/2002WO2001039799A3 Passive desensitization
01/03/2002US20020001842 Cytoplasmic transfer to de-differentiate recipient cells